Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 949.82% vs 19.92% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 615.65% vs 20.83% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 688.00% vs 28.57% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -4.17% vs 14.29% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Frontier Biotechnologies, Inc. (China) With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 1,385.50% vs -55.26% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 949.82% vs 19.92% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 310.17% vs -73.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 615.65% vs 20.83% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 310.20% vs -109.80% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 688.00% vs 28.57% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 9.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -4.17% vs 14.29% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






